
ex-10.3
4
p18000exv10w3.htm
ex-10.3

exv10w3


exhibit 10.3

first amendment to
amended and restated employment agreement

     medicis pharmaceutical corporation (the company) and jason d. hanson (the executive)
entered into an amended and restated employment agreement (the agreement) effective as of
december 22, 2008. the company and executive wish to amend the agreement to modify the
description of the executives position and duties and to clarify the circumstances in which a
change in the executives authority, duties or responsibilities will be deemed to give rise to
good reason for the executive to terminate the agreement. the company and executive each
acknowledge that the modification of the executives position and duties and the noted
clarification is valuable to it or him and provides adequate consideration for the execution
of this first amendment.

     1. this first amendment is effective as of june 30, 2010.

     2. section 2.1 of the agreement is hereby amended and restated in its entirety to read as
follows:

     2.1 position and duties. executive shall serve as the
executive vice president and chief operating officer of the
company, and shall have such authority, duties and responsibilities as
are ordinarily assigned to an employee holding the position of chief
operating officer with a publicly traded company. executive shall
also have such additional authority, duties and responsibilities as may
be assigned to him by the company from time to time with his
consent.

     3. section 3.1 of the agreement is hereby amended to provide that executives salary,
effective as of the effective date of this first amendment, shall be increased to an annual
rate of
$625,000 per year.

     4. section 5.6(b) of the agreement is hereby amended and restated in its entirety to read
as follows:

     (b) a material diminution in executives authority, duties or
responsibilities as set forth in section 2.1, provided, however, that for

 



 

purposes of this clause (b) a change in executives authority, title, duties, or responsibilities
shall not be deemed to materially reduce executives authority, duties, or responsibilities if all
of the following conditions are satisfied: (i) at the time the change is implemented
jonah shacknai is serving as companys chief executive officer; (ii) mr. shacknai
initiated or approved the change; (iii) executive continues to report to either the supervisor to
whom executive reported immediately prior to such change or a supervisor at the same or higher
level of responsibility within companys organizational structure; and (iv) there is no material
diminution in executives base compensation or in executives opportunities for incentive or equity
compensation.

     5. this first amendment amends only the provisions of the agreement as set forth herein,
and those provisions not expressly amended by this first amendment shall continue in full
force and effect. notwithstanding the foregoing, this first amendment shall supersede the
provisions of the agreement to the extent those provisions are inconsistent with the provisions and
the intent of this first amendment.

     in witness whereof, executive has executed this first amendment, and company has
caused this first amendment to be executed by its duly authorized representative, on this
15th day of june, 2010.



 
 
 
 
 


 
medicis pharmaceutical corporation
 
 

 
by  
/s/ mark a. prygocki
 
 

 
 
its mark a. prygocki 
 

 
 
executive vice president, chief operating officer 
 


 


 
executive
 
 

 
/s/ jason d. hanson
 
 

 
 
 

 
 
 


 


2



